Miniderm (Glycerol)

Glycerol acts as a humectant; it attracts and binds water molecules to the outermost skin layers. This increases the water content of the stratum corneum, reduces transepidermal water loss, and improves skin flexibility. The resulting hydration creates a protective film that soothes and supports the skin’s natural repair processes.

The specific amount of Miniderm to apply is determined by the prescribing healthcare professional based on the condition being treated, the size of the area, and patient factors. Typically, a thin layer is spread over the affected skin, but exact dosing instructions should always follow the prescriber’s guidance.

Glycerol is minimally absorbed through intact skin, and topical use is generally considered low risk. However, safety data for Miniderm in pregnancy or lactation are limited. Women who are pregnant, planning to become pregnant, or breastfeeding should consult their healthcare provider before using the product.

To place an order, submit an enquiry on the Miniderm product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide. After the request, the sales team will verify trade or institutional credentials and respond with pricing, availability, shipping details and any required import documentation.

Miniderm’s primary active ingredient, glycerol, is a simple, non‑ionic humectant that provides rapid water retention without the occlusive feel of petrolatum or the high cost of hyaluronic‑acid based products. While it may not form a heavy barrier, it offers effective hydration for mild conditions and is well‑tolerated by most skin types.

Store Miniderm at ambient temperature, preferably below 25 °C. Keep the container tightly closed, protect it from direct sunlight, moisture and extreme heat. Do not freeze the product. If the formulation appears discoloured or separated, discard it and obtain a fresh supply.

Miniderm is applied topically to the affected skin area. Clean and gently pat the skin dry, then spread a thin, even layer of the product using clean hands or a sterile applicator. The frequency of application should follow the prescriber’s instructions, typically 1–3 times daily.

The most serious risks involve allergic reactions such as contact dermatitis, which may present as redness, swelling, blistering or intense itching. In rare cases, severe skin ulceration or systemic effects from excessive absorption have been reported. Discontinue use and seek medical attention if any severe reaction occurs.

Individuals with a known allergy to glycerol or any excipients in the formulation should avoid Miniderm. It is also contraindicated on heavily infected or necrotic wounds, on mucous membranes, and in patients where the prescriber determines that another treatment is more appropriate.